Free Trial
NASDAQ:RDNT

RadNet (RDNT) Stock Price, News & Analysis

RadNet logo
$72.18 -0.66 (-0.91%)
As of 10:50 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About RadNet Stock (NASDAQ:RDNT)

Advanced

Key Stats

Today's Range
$72.01
$73.01
50-Day Range
$52.53
$78.33
52-Week Range
$45.00
$93.65
Volume
53,144 shs
Average Volume
792,631 shs
Market Capitalization
$5.55 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$76.80
Consensus Rating
Moderate Buy

Company Overview

RadNet Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
65th Percentile Overall Score

RDNT MarketRank™: 

RadNet scored higher than 65% of companies evaluated by MarketBeat, and ranked 351st out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    RadNet has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 4 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside/Downside

    The consensus price target for RadNet is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    RadNet has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about RadNet's stock forecast and price target.
  • Earnings Growth

    Earnings for RadNet are expected to decrease by -5.36% in the coming year, from $0.56 to $0.53 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of RadNet is -364.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of RadNet is -364.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    RadNet has a P/B Ratio of 4.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about RadNet's valuation and earnings.
  • Percentage of Shares Shorted

    8.36% of the outstanding shares of RadNet have been sold short.
  • Short Interest Ratio / Days to Cover

    RadNet has a short interest ratio ("days to cover") of 8.2.
  • Change versus previous month

    Short interest in RadNet has recently increased by 6.81%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    RadNet does not currently pay a dividend.

  • Dividend Growth

    RadNet does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.36% of the outstanding shares of RadNet have been sold short.
  • Short Interest Ratio / Days to Cover

    RadNet has a short interest ratio ("days to cover") of 8.2.
  • Change versus previous month

    Short interest in RadNet has recently increased by 6.81%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    RadNet has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for RadNet this week, compared to 8 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, RadNet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,430,715.00 in company stock.

  • Percentage Held by Insiders

    Only 5.60% of the stock of RadNet is held by insiders.

  • Percentage Held by Institutions

    77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about RadNet's insider trading history.
Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RDNT Stock News Headlines

Cornelis Wesdorp Sells 500 Shares of RadNet (NASDAQ:RDNT) Stock
Norman Hames Sells 10,000 Shares of RadNet (NASDAQ:RDNT) Stock
Shots officially fired…
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.tc pixel
Comparing Elanco Animal Health (NYSE:ELAN) & RadNet (NASDAQ:RDNT)
See More Headlines

RDNT Stock Analysis - Frequently Asked Questions

RadNet's stock was trading at $69.84 on January 1st, 2025. Since then, RDNT shares have increased by 4.3% and is now trading at $72.84.

RadNet, Inc. (NASDAQ:RDNT) released its quarterly earnings data on Sunday, August, 10th. The medical research company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.14. The company's quarterly revenue was up 8.4% on a year-over-year basis.
Read the conference call transcript
.

RadNet's top institutional shareholders include Voya Investment Management LLC (0.64%) and GAMMA Investing LLC. Insiders that own company stock include Alma Gregory Sorensen, Norman R Hames, David L Swartz, Lawrence L Levitt, Ranjan Jayanathan, David Jeffrey Katz, Mark Stolper, Cornelis Wesdorp, Michael N Murdock, Christine Nayoma Gordon and Gregory E Spurlock.
View institutional ownership trends
.

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that RadNet investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Broadcom (AVGO) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
8/10/2025
Today
10/09/2025
Next Earnings (Estimated)
11/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:RDNT
CIK
790526
Employees
11,021
Year Founded
1981

Price Target and Rating

High Price Target
$81.00
Low Price Target
$69.00
Potential Upside/Downside
+5.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
130.07
P/E Growth
N/A
Net Income
$2.79 million
Net Margins
-0.78%
Pretax Margin
1.19%
Return on Equity
2.41%
Return on Assets
0.82%

Debt

Debt-to-Equity Ratio
0.91
Current Ratio
2.00
Quick Ratio
2.00

Sales & Book Value

Annual Sales
$1.83 billion
Price / Sales
3.06
Cash Flow
$3.34 per share
Price / Cash Flow
21.84
Book Value
$15.31 per share
Price / Book
4.76

Miscellaneous

Outstanding Shares
76,920,000
Free Float
72,609,000
Market Cap
$5.60 billion
Optionable
Optionable
Beta
1.59

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:RDNT) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners